JPS627918B2 - - Google Patents
Info
- Publication number
- JPS627918B2 JPS627918B2 JP54107818A JP10781879A JPS627918B2 JP S627918 B2 JPS627918 B2 JP S627918B2 JP 54107818 A JP54107818 A JP 54107818A JP 10781879 A JP10781879 A JP 10781879A JP S627918 B2 JPS627918 B2 JP S627918B2
- Authority
- JP
- Japan
- Prior art keywords
- around
- absorption
- sulfuric acid
- reaction
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000126 substance Substances 0.000 claims description 33
- 230000001093 anti-cancer Effects 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 28
- 238000010521 absorption reaction Methods 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 241000605909 Fusobacterium Species 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000011481 absorbance measurement Methods 0.000 claims description 12
- 239000008363 phosphate buffer Substances 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 241000605986 Fusobacterium nucleatum Species 0.000 claims description 9
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 claims description 9
- 238000000862 absorption spectrum Methods 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 239000011800 void material Substances 0.000 claims description 8
- 241000699670 Mus sp. Species 0.000 claims description 7
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 206010003445 Ascites Diseases 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229920005654 Sephadex Polymers 0.000 claims description 4
- 239000012507 Sephadex⢠Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 201000009030 Carcinoma Diseases 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 238000000921 elemental analysis Methods 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- RJTZUHVCZIGJMB-UHFFFAOYSA-N hydron;1h-indole;chloride Chemical compound Cl.C1=CC=C2NC=CC2=C1 RJTZUHVCZIGJMB-UHFFFAOYSA-N 0.000 claims description 3
- 230000003308 immunostimulating effect Effects 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 25
- 239000000843 powder Substances 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 8
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000005757 colony formation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- -1 sodium Chemical class 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 239000004158 L-cystine Substances 0.000 description 2
- 235000019393 L-cystine Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 229940046307 sodium thioglycolate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-n,n-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- WHWDWIHXSPCOKZ-UHFFFAOYSA-N hexahydrofarnesyl acetone Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)=O WHWDWIHXSPCOKZ-UHFFFAOYSA-N 0.000 description 1
- 230000007236 host immunity Effects 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 230000002399 phagocytotic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 description 1
- DFIWJEVKLWMZBI-UHFFFAOYSA-M sodium;dihydrogen phosphate;phosphoric acid Chemical compound [Na+].OP(O)(O)=O.OP(O)([O-])=O DFIWJEVKLWMZBI-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
æ¬çºæã¯æ°èŠãªå¶çæ§ç©è³ªãæŽã«è©³çŽ°ã«ã¯ããœ
ãã¯ããªãŠã å±ã«å±ããèãå¹é€ãããã®å¹é€æ¶²
ããåŸãããå¶çæ§ç©è³ªTFâ120ã«é¢ãããæŽã«
ãŸããæ¬çºæã¯ãã®å¶çæ§ç©è³ªTFâ120ã補é ã
ãæ¹æ³äžŠã³ã«ãããå«æããå¶çå€ã«é¢ããã è¿å¹Žãåçš®ã®çæ£è ã®æ²»çæ³ã«ãããŠã宿䞻ã®
å ç«æ©èœã亢é²ãããå ç«æ©èœã®å©ããåããªã
ãå¶çå¹æãçºçŸãããæ²»çæ³ãçããšãªã€ãŠæ¥
ããæ¯ãçæ³ã«äœ¿çšãããè¬å€ãšããŠã¯ãå皮现
èã®èäœãèäœå¹é€ç©ããåŸãããæåãããã
ã¯æ åèã®åå®äœåã¯ãã®å¹é€èäœããåŸããã
å€ç³äœãç¥ãããŠããããããããããã®è¬å€ã¯
å¹æãå¯äœçšåã³ãã®è£œé æ¹æ³çã®ç¹ã§æªã æºè¶³
ãåŸããã®ã§ã¯ãªãã äžæ¹ãŸããããœãã¯ããªãŠã å±ã«å±ããèãäŸ
ãã°ããœãã¯ããªãŠã ã»K031â3Bãããœãã¯ã
ãªãŠã ã»ãã·ããªãã¹ïŒ·â12ãããœãã¯ããªãŠ
ã ã»ã®ã©ã³ã¹1012åã³ããœãã¯ããªãŠã ã»ãã¯ã¬
ã¢ã¿ã 1010ãå¹é€ããŠåŸãèäœããã³äžæž 液ã«é¢
ããå ±åãã¿ãããããå£ç§èªã23ã322ã333é
ïŒ1974ïŒãå£ç§èªã21ã534ã539é ïŒ1972ïŒãããã
ããªãããããœãã¯ããªãŠã å±ã«å±ããäžèšèã
å¹é€ãããã®å¹é€æ¶²ããåŸãããæå䞊ã³ã«ãã®
è¬çäœçšã«ã€ããŠã¯æªã ç 究ãããŠããªãã ããã§ãæ¬çºæè ã¯ãæ¬çºæè ã«ãã€ãŠããå£
è å ããåé¢ããããœãã¯ããªãŠã å±ã«å±ããè
ãå¹é€ãããã®å¹é€æ¶²ããèäœãé€å»ããäžæž 液
ã«ã€ããŠããã®è¬çäœçšã調ã¹ãŠãããšãããã
ã®äžæž 液ããæ¡åãããç¹å®ã®æåã匷ãå¶çäœ
çšãæããããšããããããã¯ãã³ãããŒåœ¢ææ
å¶æ³ã«ãããŠã¯ç现èã®éèœåœ¢æé»æ¢äœçšã¯æ¥µã
ãŠå°ããã殺现èã«ããå¶çäœçšã§ã¯ãªãã宿䞻
ä»åšæ§ãããã¯å®¿äž»ã®å ç«åã亢é²ãããå ç«å
ã®å©ããåããªããéæ¥çã«å¶çäœçšãçºçŸãã
ãäœçšãæãããã®ã§ããããšãæŽã«ãã®æåã¯
æ¯æ§ã極ããŠäœãããšãèŠåºããæ¬çºæãå®æã
ãã æ¬çºæã§äœ¿çšãããèã¯ãåœç«é沢倧åŠå»åŠéš
éå±ç é¢æ¯ç§å£è å€ç§ã«ãããŠãããå£è ããå
é¢ããããã®ã§ã次ã®ãããªèåŠçæ§ç¶ãæã
ãã (1) 圢æ 现èã®åœ¢ïŒçŽ¡é圢ïŒç¬¬ïŒå³ïŒ 现èã®å€åœ¢æ§ã®æç¡ïŒãªã éåæ§ã®æç¡ïŒãªã èåã®æç¡ïŒãªã ã°ã©ã æè²ïŒã°ã©ã é°æ§ æé žæ§ïŒé°æ§ (2) å¹å°ã«ãããçè²ç¶æ TFâïœå¯å€©å¹³æ¿åã³æé¢å¹å° å€åœ¢ïŒå圢 倧ããïŒçŽïŒmm éèµ·ïŒåçç¶ æ§é ïŒé²æ»Žç¶ è¡šé¢ïŒå¹³æ» 蟺çžïŒå¹³æ» è²ïŒä¹³é»çœè² éæ床ïŒäžéæ TFâïœæ¶²äœå¹å° çºè²ã®çšåºŠïŒæºç æ¿ãïŒåå¡ æ²æŸ±ïŒãªã è¡šé¢ã®çºè²ïŒãªããçŽïŒmmãŸã§ã¯çºè²ãªã ã¬ã¹ïŒãªã (3) ççåŠçæ§è³ª ç¡«åæ°ŽçŽ ã®çæïŒïŒ ç¡é žå¡©ã®éå ïŒâ é ªé žã®çæïŒïŒ ã€ã³ããŒã«ã®çæïŒïŒ ãŠã¬ã¢ãŒãŒïŒâ ã«ã¿ã©ãŒãŒïŒâ ãã³ãã³ã®å æ°Žå解ïŒâ é žçŽ ã«å¯Ÿããæ 床ïŒå«æ°æ§ ã¢ã³ã¢ãã¢ã®çæïŒïŒ çé žã¬ã¹ã®çæïŒïŒ çè²ã®ç¯å²ïŒPHïŒã7.5 枩床30ã45â ç³ããã®ã¬ã¹ã®çæ âã¢ã©ããããŒã¹ïŒâïŒãâãã·ããŒ
ã¹ïŒâïŒãâã°ã«ã³ãŒã¹ïŒâïŒãâãã³ã
ãŒã¹ïŒâïŒãâãã©ã¯ããŒã¹ïŒâïŒãâã¬
ã©ã¯ããŒã¹ïŒâïŒã麊èœç³ïŒâïŒãã·ãšç³
ïŒâïŒããã¬ãããŒã¹ïŒâïŒããœã«ããã
ïŒâïŒããã³ãããŒã«ïŒâïŒãã€ãã·ãã
ïŒâïŒãã°ãªã»ãªã³ïŒâïŒããã³ãã³ïŒâïŒ ä»¥äžã®è«žæ§ç¶ãããŒãžãŒãºã»ãããŠã¢ã«ã»ãª
ãã»ãã€ã¿ããã€ãã€ãã»ãã¯ããªãªããžãŒç¬¬ïŒ
çã«ç §ããŠæ€èšãããšãæ¬èæ ªã¯ããœãã¯ããªãŠ
ã ã»ãã¯ã¬ã¢ã¿ã ïŒFusobacterium
nucleatumïŒã«é ·äŒŒããã®ã§ãããã«å±ããèã§
ãããšåå®ããæ¬èæ ªãããœãã¯ããªãŠã ã»ãã¯
ã¬ã¢ã¿ã TFâ031ïŒFusobacterium nucleatum
TFâ031ïŒãšåœåããŠãå·¥æ¥æè¡é¢åŸ®çç©å·¥æ¥æ
è¡ç 究æã«åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·
ïŒFERMâ No.5077ïŒããŠå¯èšããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã¯äŸãã°æ¬¡ã®åŠã
ããŠè£œé ãããã (a) å¹é€ ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã ã®å¹é€ã¯ã
éåžžã®å«æ°æ§èã®å¹é€æ³ã«ãã€ãŠè¡ããããã
ãªãã¡ãåçš®ãããã³ãçã®è³ãå¿èæœåºç©ç
ã®çªçŽ æºïŒã°ã«ã³ãŒã¹ãã©ã¯ããŒã¹çã®ççŽ
æºïŒã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯ãçã®ãã¿ãã³
æºïŒïŒ¬âã·ã¹ãã³ãäºç¡«é žãœãŒããããªã°ãªã³
ã¬ãŒãçã®éå å€ïŒå¡©åãããªãŠã çã®ç¡æ©å¡©
ãå«ãå¹å°ãæ°Žé žåãããªãŠã ã§PHïŒã«èª¿æŽã
ããã®ãçšããŠãå«æ°çæ¡ä»¶äž30ã40âã®æž©åºŠ
ã§ïŒãïŒæ¥éé眮å¹é€ãè¡ããç¹ã«æ¬¡ã®æåã
å«ãå¹å°ïŒä»¥äžTFå¹å°ãšç§°ããïŒã䜿çšãã
ã®ã奜ãŸããããªããå¯å€©ã䜿çšããªããšãã¯
æ¹æå¹é€ãè¡ãã®ã奜ãŸããã
ãã¯ããªãŠã å±ã«å±ããèãå¹é€ãããã®å¹é€æ¶²
ããåŸãããå¶çæ§ç©è³ªTFâ120ã«é¢ãããæŽã«
ãŸããæ¬çºæã¯ãã®å¶çæ§ç©è³ªTFâ120ã補é ã
ãæ¹æ³äžŠã³ã«ãããå«æããå¶çå€ã«é¢ããã è¿å¹Žãåçš®ã®çæ£è ã®æ²»çæ³ã«ãããŠã宿䞻ã®
å ç«æ©èœã亢é²ãããå ç«æ©èœã®å©ããåããªã
ãå¶çå¹æãçºçŸãããæ²»çæ³ãçããšãªã€ãŠæ¥
ããæ¯ãçæ³ã«äœ¿çšãããè¬å€ãšããŠã¯ãå皮现
èã®èäœãèäœå¹é€ç©ããåŸãããæåãããã
ã¯æ åèã®åå®äœåã¯ãã®å¹é€èäœããåŸããã
å€ç³äœãç¥ãããŠããããããããããã®è¬å€ã¯
å¹æãå¯äœçšåã³ãã®è£œé æ¹æ³çã®ç¹ã§æªã æºè¶³
ãåŸããã®ã§ã¯ãªãã äžæ¹ãŸããããœãã¯ããªãŠã å±ã«å±ããèãäŸ
ãã°ããœãã¯ããªãŠã ã»K031â3Bãããœãã¯ã
ãªãŠã ã»ãã·ããªãã¹ïŒ·â12ãããœãã¯ããªãŠ
ã ã»ã®ã©ã³ã¹1012åã³ããœãã¯ããªãŠã ã»ãã¯ã¬
ã¢ã¿ã 1010ãå¹é€ããŠåŸãèäœããã³äžæž 液ã«é¢
ããå ±åãã¿ãããããå£ç§èªã23ã322ã333é
ïŒ1974ïŒãå£ç§èªã21ã534ã539é ïŒ1972ïŒãããã
ããªãããããœãã¯ããªãŠã å±ã«å±ããäžèšèã
å¹é€ãããã®å¹é€æ¶²ããåŸãããæå䞊ã³ã«ãã®
è¬çäœçšã«ã€ããŠã¯æªã ç 究ãããŠããªãã ããã§ãæ¬çºæè ã¯ãæ¬çºæè ã«ãã€ãŠããå£
è å ããåé¢ããããœãã¯ããªãŠã å±ã«å±ããè
ãå¹é€ãããã®å¹é€æ¶²ããèäœãé€å»ããäžæž 液
ã«ã€ããŠããã®è¬çäœçšã調ã¹ãŠãããšãããã
ã®äžæž 液ããæ¡åãããç¹å®ã®æåã匷ãå¶çäœ
çšãæããããšããããããã¯ãã³ãããŒåœ¢ææ
å¶æ³ã«ãããŠã¯ç现èã®éèœåœ¢æé»æ¢äœçšã¯æ¥µã
ãŠå°ããã殺现èã«ããå¶çäœçšã§ã¯ãªãã宿䞻
ä»åšæ§ãããã¯å®¿äž»ã®å ç«åã亢é²ãããå ç«å
ã®å©ããåããªããéæ¥çã«å¶çäœçšãçºçŸãã
ãäœçšãæãããã®ã§ããããšãæŽã«ãã®æåã¯
æ¯æ§ã極ããŠäœãããšãèŠåºããæ¬çºæãå®æã
ãã æ¬çºæã§äœ¿çšãããèã¯ãåœç«é沢倧åŠå»åŠéš
éå±ç é¢æ¯ç§å£è å€ç§ã«ãããŠãããå£è ããå
é¢ããããã®ã§ã次ã®ãããªèåŠçæ§ç¶ãæã
ãã (1) 圢æ 现èã®åœ¢ïŒçŽ¡é圢ïŒç¬¬ïŒå³ïŒ 现èã®å€åœ¢æ§ã®æç¡ïŒãªã éåæ§ã®æç¡ïŒãªã èåã®æç¡ïŒãªã ã°ã©ã æè²ïŒã°ã©ã é°æ§ æé žæ§ïŒé°æ§ (2) å¹å°ã«ãããçè²ç¶æ TFâïœå¯å€©å¹³æ¿åã³æé¢å¹å° å€åœ¢ïŒå圢 倧ããïŒçŽïŒmm éèµ·ïŒåçç¶ æ§é ïŒé²æ»Žç¶ è¡šé¢ïŒå¹³æ» 蟺çžïŒå¹³æ» è²ïŒä¹³é»çœè² éæ床ïŒäžéæ TFâïœæ¶²äœå¹å° çºè²ã®çšåºŠïŒæºç æ¿ãïŒåå¡ æ²æŸ±ïŒãªã è¡šé¢ã®çºè²ïŒãªããçŽïŒmmãŸã§ã¯çºè²ãªã ã¬ã¹ïŒãªã (3) ççåŠçæ§è³ª ç¡«åæ°ŽçŽ ã®çæïŒïŒ ç¡é žå¡©ã®éå ïŒâ é ªé žã®çæïŒïŒ ã€ã³ããŒã«ã®çæïŒïŒ ãŠã¬ã¢ãŒãŒïŒâ ã«ã¿ã©ãŒãŒïŒâ ãã³ãã³ã®å æ°Žå解ïŒâ é žçŽ ã«å¯Ÿããæ 床ïŒå«æ°æ§ ã¢ã³ã¢ãã¢ã®çæïŒïŒ çé žã¬ã¹ã®çæïŒïŒ çè²ã®ç¯å²ïŒPHïŒã7.5 枩床30ã45â ç³ããã®ã¬ã¹ã®çæ âã¢ã©ããããŒã¹ïŒâïŒãâãã·ããŒ
ã¹ïŒâïŒãâã°ã«ã³ãŒã¹ïŒâïŒãâãã³ã
ãŒã¹ïŒâïŒãâãã©ã¯ããŒã¹ïŒâïŒãâã¬
ã©ã¯ããŒã¹ïŒâïŒã麊èœç³ïŒâïŒãã·ãšç³
ïŒâïŒããã¬ãããŒã¹ïŒâïŒããœã«ããã
ïŒâïŒããã³ãããŒã«ïŒâïŒãã€ãã·ãã
ïŒâïŒãã°ãªã»ãªã³ïŒâïŒããã³ãã³ïŒâïŒ ä»¥äžã®è«žæ§ç¶ãããŒãžãŒãºã»ãããŠã¢ã«ã»ãª
ãã»ãã€ã¿ããã€ãã€ãã»ãã¯ããªãªããžãŒç¬¬ïŒ
çã«ç §ããŠæ€èšãããšãæ¬èæ ªã¯ããœãã¯ããªãŠ
ã ã»ãã¯ã¬ã¢ã¿ã ïŒFusobacterium
nucleatumïŒã«é ·äŒŒããã®ã§ãããã«å±ããèã§
ãããšåå®ããæ¬èæ ªãããœãã¯ããªãŠã ã»ãã¯
ã¬ã¢ã¿ã TFâ031ïŒFusobacterium nucleatum
TFâ031ïŒãšåœåããŠãå·¥æ¥æè¡é¢åŸ®çç©å·¥æ¥æ
è¡ç 究æã«åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·
ïŒFERMâ No.5077ïŒããŠå¯èšããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã¯äŸãã°æ¬¡ã®åŠã
ããŠè£œé ãããã (a) å¹é€ ããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã ã®å¹é€ã¯ã
éåžžã®å«æ°æ§èã®å¹é€æ³ã«ãã€ãŠè¡ããããã
ãªãã¡ãåçš®ãããã³ãçã®è³ãå¿èæœåºç©ç
ã®çªçŽ æºïŒã°ã«ã³ãŒã¹ãã©ã¯ããŒã¹çã®ççŽ
æºïŒã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯ãçã®ãã¿ãã³
æºïŒïŒ¬âã·ã¹ãã³ãäºç¡«é žãœãŒããããªã°ãªã³
ã¬ãŒãçã®éå å€ïŒå¡©åãããªãŠã çã®ç¡æ©å¡©
ãå«ãå¹å°ãæ°Žé žåãããªãŠã ã§PHïŒã«èª¿æŽã
ããã®ãçšããŠãå«æ°çæ¡ä»¶äž30ã40âã®æž©åºŠ
ã§ïŒãïŒæ¥éé眮å¹é€ãè¡ããç¹ã«æ¬¡ã®æåã
å«ãå¹å°ïŒä»¥äžTFå¹å°ãšç§°ããïŒã䜿çšãã
ã®ã奜ãŸããããªããå¯å€©ã䜿çšããªããšãã¯
æ¹æå¹é€ãè¡ãã®ã奜ãŸããã
ãè¡šã
ãè¡šã
(b) å¹é€æ¶²ããäžæž
液ã®æ¡åïŒèäœã®é€å»ïŒ
äžã§åŸãå¹é€æ¶²ããèäœãé€å»ããŠäžæž
液ã
åŸããèäœã®é€å»ã¯åžžæ³ãäŸãã°é å¿åé¢ãã
ã€ããã¹ãŒããŒã²ã«çã®éå©å€ãçšããé
æ³ãæ¡çšã§ããããç¹ã«é å¿åé¢æ³ã¯æäœãè
ã®é€å»åºŠåãäžæž 液ã®ååŸéã®ç¹ã§å¥œãŸããã
åèäœã®é€å»ã¯ãã®æ®µéã§è¡ãªãã®ã奜ãŸãã
ãã次ã®(c)ã®æäœã«ãããŠé€å»ããŠãããã (c) å¶çæ§ç©è³ªTFâ120ã®æ¡å (ã€) äžã§åŸãããäžæž 液åã¯å¹é€æ¶²ã«èŠªæ°Žæ§æ
æ©æº¶åªãå ããŠãçããæ²æŸ±ç©ãæ¡åããã
ãã®éã®äžæž 液åã¯å¹é€æ¶²ã¯PHïŒãïŒã«èª¿æŽ
ããã®ã奜ãŸããã芪氎æ§ææ©æº¶åªãšããŠ
ã¯ãäŸãã°ãšã¿ããŒã«ãã¡ã¿ããŒã«çã®ã¢ã«
ã³ãŒã«é¡ãã¢ã»ãã³çã®ã±ãã³é¡ãæããã
ãããã¢ã«ã³ãŒã«é¡ç¹ã«ãšã¿ããŒã«ãæãã
ãçµæãäžããããã®èŠªæ°Žæ§ææ©æº¶åªã¯ãã®
æ¿åºŠã30ã70ïŒ ã奜ãŸããã¯60ïŒ ååŸã«ãªã
ããã«æ·»å ããã®ã奜é©ã§ããã芪氎æ§ææ©
溶åªãå ããåŸãäœæž©ã奜ãŸããã¯çŽïŒâã®
枩床ã§æ°æéãæ°æ¥éæŸçœ®ããæ²æŸ±ç©ã®çæ
ãå®çµãããã ãã®ããã«ããŠçããæ²æŸ±ç©ããã«ã³ããŒ
ã·ãšã³ãé å¿åé¢ãéçã®éåžžã®æäœã§å
é¢ããã 次ãã§ãäžã§åŸãããæ²æŸ±ç©ã«10ã15åé
ã®æ°Žãå ããçããæ°Žäžæº¶ç©ãé å¿åé¢ã
éçã®éåžžã®æ¹æ³ã§é€å»ãããå¹é€æ¶²ã䜿çš
ãããšãã¯ããã®åŠçã«ããèäœã¯é€å»ãã
ãã æ¯ãããŠåŸããã溶液ãåçµä¹Ÿç¥çã®åŠç
ãè¡ãã°TFâ100ãåŸãããã (ã) æ¯ãããŠåŸããã溶液ããåã¯ãã®æº¶æ¶²ã
åçµä¹Ÿç¥çã«ãã€ãŠä¹Ÿç¥ããŠåŸãTFâ100ã®
ç²æ«ã10ã15åéã®æ°Žã«æº¶è§£ãã溶液ãéæ
åã¯éå€éãããåœè©²åŠçã«ããã¢ããé ž
çã®äœååæåãé€å»ããããéæå 液åã¯
éå€éã®å 液ãæ¡åããããå 液ã也ç¥ã
ãã°ãå¶çæ§ç©è³ªTFâ110ã®çœç°è²ãæ·¡è€è²
ã®ç²æ«ãåŸãã (ã) (ã)ã§åŸãå 液ããåã¯TFâ110ã®ç²æ«ãå°
éã®æ°Žã«æº¶ããããã®ãã€ãªã³äº€æäœåŠçã
ããã€ãªã³äº€æäœãšããŠã¯åŒ±å¡©åºæ§ã€ãªã³äº€
æäœãŸãã¯åå篩æ§ã䜵æãããã®ã䜿çšã
ãã®ã奜ãŸãããäŸãã°ãžãšãã«ã¢ãããšã
ã«âã»ãã¢ããã¯ã¹ïŒ¡â50ïŒãã¢ã«ãã·ã¢ç€Ÿ
補åååïŒã奜é©ã«äœ¿çšããããã€ãªã³äº€æ
äœãå å¡«ããã«ã©ã ã¯äŸãã°PHïŒã®0.025ã¢
ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããããã«äžèšè¢«åŠ
ç液ãééãããéé液ãæéãããããã«
奜ãŸããã¯éåžçéšãæŽãåºãç®çã§äžèšãª
ã³é žç·©è¡æ¶²ãééãããéé液ãæéããã ãŸããã«ã©ã ãçšãã代ãã«å®¹åšã«ã€ãªã³
亀æäœãå ¥ããã€ãã§åäžã®ãªã³é žç·©è¡æ¶²ã§
平衡åããåŸã被åŠç液ãå ¥ãæ¹æããé
ããŠã液ãæéããŠãããã ãããã®éé液åã¯æ¶²ãåçµä¹Ÿç¥çã«ã
ã€ãŠä¹Ÿç¥ããã°ç®çã®å¶çæ§ç©è³ªTFâ120ã
åŸããããããããã®éé液åã¯æ¶²ãæŽã«
ã»ããã¢ã³ããŠãŒãçã«ããéæåã¯ã»ãã¢
ããã¯ã¹ïŒ§â25ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ
ãçšãããéå€éçã«ãã€ãŠè±å¡©ããåŸä¹Ÿ
ç¥ããããšãã§ããã 以äžã®ããšãããŠåŸãããæ°èŠå¶çæ§ç©è³ªTF
â120ã¯æ¬¡ã®ããšãç©æ§ãæããã (ã€) çœç°è²ãªããæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°Žåçã®å¢æ®ãé»æ¢
ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ãããã®æ°Žæº¶æ¶²ã¯ã»ãŒäžæ§ã瀺ãã
ã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»ãã³ããã³ãŒ
ã³ãã¯ãããã«ã ãé ¢é žãšãã«ããžãšãã«ãšãŒ
ãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ã2960ã2930ã1670ã1640ã1550ã
1380ã1360ã1140ã1000åã³820cm-1ã®è¿åã«
åžå垯ãæããïŒç¬¬ïŒå³ïŒã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€éšåžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã268ã272nïœã®è¿å
ã«åžåããŒã¯ã瀺ãã0.02ïŒ æ°Žæº¶æ¶²ã§ã®O.D260
ã¯0.060ã0.070ã®åžåã瀺ãïŒç¬¬ïŒå³ïŒã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®
ç»é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ44mmÏ
Ã500mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒ
ã§åç»ãããšã260nïœã®çŽ«å€ç·åžå 床枬å®ã«
ãããŠã¯ãã€ãããªãŠã ééä»è¿ãã325mlä»
è¿ã«ãããŠãããã³775ãã875mlä»è¿ã«ãããŠ
åžå垯ãæããããšããŒã«ç¡«é žæ³ã«ããã
490nïœã®åžå 床枬å®ã«ãããŠã¯ããã€ãããª
ãŠã ééä»è¿ãã360ã360ãã480ããã³510ã
ã760mlä»è¿ã«ãããŠåžå垯ãæããã¢ã³ã¹ã
ã³ç¡«é žæ³ã«ããã620nïœã®åžå 床枬å®ã«ãã
ãŠã¯ãã€ãããªãŠã ééä»è¿ãã380ã420ãã
520ããã³620ãã760mlä»è¿ã«ãããŠåžå垯ã
æããïŒç¬¬ïŒå³ïŒã (ã) TSKâGEL G300 SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿã®
åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ãã
é«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®0.1
ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒã¯ã
220nïœããã³260nïœã®çŽ«å€ç·åžå 床枬å®ã«ã
ããŠã¯ãããã溶åªå 端éšåã38ã60åä»è¿ã«
ãããŠããŒã¯ãæããïŒç¬¬ïŒå³ïŒã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«âç¡«é žåå¿ã
ã¢ã³ã¹ãã³âç¡«é žåå¿ãã€ã³ããŒã«âå¡©é žå
å¿ãããŠãªã€ãŒããªãªã³åå¿ã¯éœæ§ããã³ãã
ãªã³åå¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ35.1ïŒ ã40.2ïŒ ïŒšïŒ4.5ïŒ ã5.5ïŒ ïŒ®ïŒ2.0ïŒ ã3.1ïŒ (ã«) ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯56.0
ïŒ ã73.0ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ããŠãª
ã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯9.0
ïŒ ã13.0ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§ããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã®è¬çäœçšã¯æ¬¡ã®
ãšããã§ããã (1) ç现èã®éèœåœ¢æé»æ¢äœçš ãã ã»ãžãšãŒã»ãšãããã®æ¹æ³ãCancer
Res.ã25ã698ïŒ1965ïŒãã«åŸã€ãŠãHela â
ïŒçŽ°èãããŠã·è¡æž 10ïŒ æ·»å ã€ãŒã°ã«ã¹MEM
å¹å°ã§ïŒãïŒæ¥éå¹é€åŸãå¹é€æ¶²ãé€å»ããšã
ã¬ã³ãžã¢ãã³ããã©é ¢é ž0.01ïŒ åã³ããªãã·ã³
0.1ïŒ ãå«ãPBSïŒâïŒæº¶æ¶²ïŒïŒäžã«å¡©åã
ããªãŠã 8.0ïœãå¡©åã«ãªãŠã 0.2ïœããªã³é žå¡©
âæ°ŽçŽ ãããªãŠã 1.15ïœåã³ãªã³é žç¬¬äºæ°ŽçŽ ã«
ãªãŠã 0.2ïœãå«æãã氎溶液ïŒãå ããå¹é€
ã³ãã®ã¬ã©ã¹è¡šé¢ãã现èãã¯ããããŠã·è¡æž
20ïŒ æ·»å ã€ãŒã°ã«ã¹MEMå¹å°ã«ãŠåžéããåž
é液ïŒmlåœã200åã®çŽ°èãå«ãããã«èª¿è£œã
ãããã®çŽ°èæžæ¿æ¶²ïŒmlãCO2ã€ã³ããŠããŒã¿
ãŒã§37âã24æéå¹é€ããåŸãå®æœäŸïŒ(1)ã§åŸ
ãäžæž 液ã1/16ã1/128ååžéã«ãªãããã«å
ããããŸããåèšã®37âã24æéå¹é€ããã®ã¡
æ¬çºæã®å¶çæ§ç©è³ªTFâ120ãå ãïŒæ¥é
Hela现èãå¹é€ãããå¹é€åŸå¹å°ãé€å»ãã
ãã³ã¯ã¹æ°æº¶æ¶²ã«ãŠå¹é€ç¿ãæŽãã70ïŒ ãšã¿ã
ãŒã«ã«ãŠçŽ°èãåºå®ãã次ãã§100ïŒ ãšã¿ããŒ
ã«ã§çŽ°èãæŽãããšã¿ããŒã«ãé€å»ããåŸã®ã
ã¶æè²æ¶²ã§çŽ°èãæè²ããã³ãããŒæ°ãæ°ããŠ
现èã®çåçãæ±ããã ãã®çµæã¯è¡šïŒåã³è¡šïŒã®ãšããã§ãããå°
è¡šäžã®çŽ°èã®çåçã¯æ¬¡åŒã«ãã€ãŠç®åºããïŒ
æã®ã·ã€ãŒã¬ã®å¹³åå€ã§ç€ºããã 现èã®çåçïŒåŠç矀ã®ã³ãããŒæ°ïŒç¡åŠç矀ã®ã³ã
ããŒæ°Ã100
åŸããèäœã®é€å»ã¯åžžæ³ãäŸãã°é å¿åé¢ãã
ã€ããã¹ãŒããŒã²ã«çã®éå©å€ãçšããé
æ³ãæ¡çšã§ããããç¹ã«é å¿åé¢æ³ã¯æäœãè
ã®é€å»åºŠåãäžæž 液ã®ååŸéã®ç¹ã§å¥œãŸããã
åèäœã®é€å»ã¯ãã®æ®µéã§è¡ãªãã®ã奜ãŸãã
ãã次ã®(c)ã®æäœã«ãããŠé€å»ããŠãããã (c) å¶çæ§ç©è³ªTFâ120ã®æ¡å (ã€) äžã§åŸãããäžæž 液åã¯å¹é€æ¶²ã«èŠªæ°Žæ§æ
æ©æº¶åªãå ããŠãçããæ²æŸ±ç©ãæ¡åããã
ãã®éã®äžæž 液åã¯å¹é€æ¶²ã¯PHïŒãïŒã«èª¿æŽ
ããã®ã奜ãŸããã芪氎æ§ææ©æº¶åªãšããŠ
ã¯ãäŸãã°ãšã¿ããŒã«ãã¡ã¿ããŒã«çã®ã¢ã«
ã³ãŒã«é¡ãã¢ã»ãã³çã®ã±ãã³é¡ãæããã
ãããã¢ã«ã³ãŒã«é¡ç¹ã«ãšã¿ããŒã«ãæãã
ãçµæãäžããããã®èŠªæ°Žæ§ææ©æº¶åªã¯ãã®
æ¿åºŠã30ã70ïŒ ã奜ãŸããã¯60ïŒ ååŸã«ãªã
ããã«æ·»å ããã®ã奜é©ã§ããã芪氎æ§ææ©
溶åªãå ããåŸãäœæž©ã奜ãŸããã¯çŽïŒâã®
枩床ã§æ°æéãæ°æ¥éæŸçœ®ããæ²æŸ±ç©ã®çæ
ãå®çµãããã ãã®ããã«ããŠçããæ²æŸ±ç©ããã«ã³ããŒ
ã·ãšã³ãé å¿åé¢ãéçã®éåžžã®æäœã§å
é¢ããã 次ãã§ãäžã§åŸãããæ²æŸ±ç©ã«10ã15åé
ã®æ°Žãå ããçããæ°Žäžæº¶ç©ãé å¿åé¢ã
éçã®éåžžã®æ¹æ³ã§é€å»ãããå¹é€æ¶²ã䜿çš
ãããšãã¯ããã®åŠçã«ããèäœã¯é€å»ãã
ãã æ¯ãããŠåŸããã溶液ãåçµä¹Ÿç¥çã®åŠç
ãè¡ãã°TFâ100ãåŸãããã (ã) æ¯ãããŠåŸããã溶液ããåã¯ãã®æº¶æ¶²ã
åçµä¹Ÿç¥çã«ãã€ãŠä¹Ÿç¥ããŠåŸãTFâ100ã®
ç²æ«ã10ã15åéã®æ°Žã«æº¶è§£ãã溶液ãéæ
åã¯éå€éãããåœè©²åŠçã«ããã¢ããé ž
çã®äœååæåãé€å»ããããéæå 液åã¯
éå€éã®å 液ãæ¡åããããå 液ã也ç¥ã
ãã°ãå¶çæ§ç©è³ªTFâ110ã®çœç°è²ãæ·¡è€è²
ã®ç²æ«ãåŸãã (ã) (ã)ã§åŸãå 液ããåã¯TFâ110ã®ç²æ«ãå°
éã®æ°Žã«æº¶ããããã®ãã€ãªã³äº€æäœåŠçã
ããã€ãªã³äº€æäœãšããŠã¯åŒ±å¡©åºæ§ã€ãªã³äº€
æäœãŸãã¯åå篩æ§ã䜵æãããã®ã䜿çšã
ãã®ã奜ãŸãããäŸãã°ãžãšãã«ã¢ãããšã
ã«âã»ãã¢ããã¯ã¹ïŒ¡â50ïŒãã¢ã«ãã·ã¢ç€Ÿ
補åååïŒã奜é©ã«äœ¿çšããããã€ãªã³äº€æ
äœãå å¡«ããã«ã©ã ã¯äŸãã°PHïŒã®0.025ã¢
ã«ãªã³é žç·©è¡æ¶²ã§å¹³è¡¡åããããã«äžèšè¢«åŠ
ç液ãééãããéé液ãæéãããããã«
奜ãŸããã¯éåžçéšãæŽãåºãç®çã§äžèšãª
ã³é žç·©è¡æ¶²ãééãããéé液ãæéããã ãŸããã«ã©ã ãçšãã代ãã«å®¹åšã«ã€ãªã³
亀æäœãå ¥ããã€ãã§åäžã®ãªã³é žç·©è¡æ¶²ã§
平衡åããåŸã被åŠç液ãå ¥ãæ¹æããé
ããŠã液ãæéããŠãããã ãããã®éé液åã¯æ¶²ãåçµä¹Ÿç¥çã«ã
ã€ãŠä¹Ÿç¥ããã°ç®çã®å¶çæ§ç©è³ªTFâ120ã
åŸããããããããã®éé液åã¯æ¶²ãæŽã«
ã»ããã¢ã³ããŠãŒãçã«ããéæåã¯ã»ãã¢
ããã¯ã¹ïŒ§â25ïŒãã¢ã«ãã·ã¢ç€Ÿè£œåååïŒ
ãçšãããéå€éçã«ãã€ãŠè±å¡©ããåŸä¹Ÿ
ç¥ããããšãã§ããã 以äžã®ããšãããŠåŸãããæ°èŠå¶çæ§ç©è³ªTF
â120ã¯æ¬¡ã®ããšãç©æ§ãæããã (ã€) çœç°è²ãªããæ·¡è€è²ã®ç²æ«ã (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°Žåçã®å¢æ®ãé»æ¢
ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ãããã®æ°Žæº¶æ¶²ã¯ã»ãŒäžæ§ã瀺ãã
ã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»ãã³ããã³ãŒ
ã³ãã¯ãããã«ã ãé ¢é žãšãã«ããžãšãã«ãšãŒ
ãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ã2960ã2930ã1670ã1640ã1550ã
1380ã1360ã1140ã1000åã³820cm-1ã®è¿åã«
åžå垯ãæããïŒç¬¬ïŒå³ïŒã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€éšåžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã268ã272nïœã®è¿å
ã«åžåããŒã¯ã瀺ãã0.02ïŒ æ°Žæº¶æ¶²ã§ã®O.D260
ã¯0.060ã0.070ã®åžåã瀺ãïŒç¬¬ïŒå³ïŒã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®
ç»é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ44mmÏ
Ã500mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒ
ã§åç»ãããšã260nïœã®çŽ«å€ç·åžå 床枬å®ã«
ãããŠã¯ãã€ãããªãŠã ééä»è¿ãã325mlä»
è¿ã«ãããŠãããã³775ãã875mlä»è¿ã«ãããŠ
åžå垯ãæããããšããŒã«ç¡«é žæ³ã«ããã
490nïœã®åžå 床枬å®ã«ãããŠã¯ããã€ãããª
ãŠã ééä»è¿ãã360ã360ãã480ããã³510ã
ã760mlä»è¿ã«ãããŠåžå垯ãæããã¢ã³ã¹ã
ã³ç¡«é žæ³ã«ããã620nïœã®åžå 床枬å®ã«ãã
ãŠã¯ãã€ãããªãŠã ééä»è¿ãã380ã420ãã
520ããã³620ãã760mlä»è¿ã«ãããŠåžå垯ã
æããïŒç¬¬ïŒå³ïŒã (ã) TSKâGEL G300 SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿã®
åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ãã
é«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®0.1
ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒã¯ã
220nïœããã³260nïœã®çŽ«å€ç·åžå 床枬å®ã«ã
ããŠã¯ãããã溶åªå 端éšåã38ã60åä»è¿ã«
ãããŠããŒã¯ãæããïŒç¬¬ïŒå³ïŒã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«âç¡«é žåå¿ã
ã¢ã³ã¹ãã³âç¡«é žåå¿ãã€ã³ããŒã«âå¡©é žå
å¿ãããŠãªã€ãŒããªãªã³åå¿ã¯éœæ§ããã³ãã
ãªã³åå¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ35.1ïŒ ã40.2ïŒ ïŒšïŒ4.5ïŒ ã5.5ïŒ ïŒ®ïŒ2.0ïŒ ã3.1ïŒ (ã«) ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯56.0
ïŒ ã73.0ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ããŠãª
ã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯9.0
ïŒ ã13.0ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§ããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã®è¬çäœçšã¯æ¬¡ã®
ãšããã§ããã (1) ç现èã®éèœåœ¢æé»æ¢äœçš ãã ã»ãžãšãŒã»ãšãããã®æ¹æ³ãCancer
Res.ã25ã698ïŒ1965ïŒãã«åŸã€ãŠãHela â
ïŒçŽ°èãããŠã·è¡æž 10ïŒ æ·»å ã€ãŒã°ã«ã¹MEM
å¹å°ã§ïŒãïŒæ¥éå¹é€åŸãå¹é€æ¶²ãé€å»ããšã
ã¬ã³ãžã¢ãã³ããã©é ¢é ž0.01ïŒ åã³ããªãã·ã³
0.1ïŒ ãå«ãPBSïŒâïŒæº¶æ¶²ïŒïŒäžã«å¡©åã
ããªãŠã 8.0ïœãå¡©åã«ãªãŠã 0.2ïœããªã³é žå¡©
âæ°ŽçŽ ãããªãŠã 1.15ïœåã³ãªã³é žç¬¬äºæ°ŽçŽ ã«
ãªãŠã 0.2ïœãå«æãã氎溶液ïŒãå ããå¹é€
ã³ãã®ã¬ã©ã¹è¡šé¢ãã现èãã¯ããããŠã·è¡æž
20ïŒ æ·»å ã€ãŒã°ã«ã¹MEMå¹å°ã«ãŠåžéããåž
é液ïŒmlåœã200åã®çŽ°èãå«ãããã«èª¿è£œã
ãããã®çŽ°èæžæ¿æ¶²ïŒmlãCO2ã€ã³ããŠããŒã¿
ãŒã§37âã24æéå¹é€ããåŸãå®æœäŸïŒ(1)ã§åŸ
ãäžæž 液ã1/16ã1/128ååžéã«ãªãããã«å
ããããŸããåèšã®37âã24æéå¹é€ããã®ã¡
æ¬çºæã®å¶çæ§ç©è³ªTFâ120ãå ãïŒæ¥é
Hela现èãå¹é€ãããå¹é€åŸå¹å°ãé€å»ãã
ãã³ã¯ã¹æ°æº¶æ¶²ã«ãŠå¹é€ç¿ãæŽãã70ïŒ ãšã¿ã
ãŒã«ã«ãŠçŽ°èãåºå®ãã次ãã§100ïŒ ãšã¿ããŒ
ã«ã§çŽ°èãæŽãããšã¿ããŒã«ãé€å»ããåŸã®ã
ã¶æè²æ¶²ã§çŽ°èãæè²ããã³ãããŒæ°ãæ°ããŠ
现èã®çåçãæ±ããã ãã®çµæã¯è¡šïŒåã³è¡šïŒã®ãšããã§ãããå°
è¡šäžã®çŽ°èã®çåçã¯æ¬¡åŒã«ãã€ãŠç®åºããïŒ
æã®ã·ã€ãŒã¬ã®å¹³åå€ã§ç€ºããã 现èã®çåçïŒåŠç矀ã®ã³ãããŒæ°ïŒç¡åŠç矀ã®ã³ã
ããŒæ°Ã100
ãè¡šã
ãè¡šã
ãè¡šã
ãã®å®éšããæãããªåŠããå¶çæ§ç©è³ªTF
â120ã®äžæž 液ãšæ¯èŒãããšãçŽæ¥çãªçŽ°èå·
害äœçšã§ããç现èã®éèœåœ¢æé»æ¢äœçšã¯ãã
ããŠåŒ±ãã (2) å ç«è³ŠæŽ»äœçš äžçŸ€ïŒå¹ã®ICRç³»ããŠã¹ãçšããå¶çæ§ç©è³ª
TFâ120ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ããïŒmgå
ã³20mgïŒKgãè ¹è å æäžãããæäž24æéåŸã«
Perikan Drawing Ink 17 BlackïŒã®ãŠã³ã¿
ãŒã»ã¯ã°ããŒç€Ÿè£œïŒïŒmlãšãŒã©ãã³ïŒïŒ å«æç
çé£å¡©æ°ŽïŒmlãæ··åããŠèª¿è£œããã«ãŒãã³æµ®é
液0.2mlãããŠã¹å°Ÿéèããæ³šå ¥ããæ³šå ¥åŸ
ïŒãïŒã10ããã³15ååŸã«çŒçª©ãããããªã³è¢«
èŠãããã¯ãªããæ¯çŽ°ç®¡ãçšããŠè¡æ¶²0.02mlã
æ¡åããçŽã¡ã«0.1ïŒ çé žãããªãŠã 氎溶液1.6
mlã«åžé溶è¡ããããããæ³¢é·675nïœã§æ¯è²
ã貧é£ä¿æ°ïŒphagocytotic indexïŒïŒïŒ«å€ã
Halpernãã®æ°åŒã«ããæ±ããã ãŸãå¯Ÿç §çŸ€ã«ã¯ççé£å¡©æ°Ž0.2mlãæäžã
ãã ïŒïœïœïœ ïœâïœïœïœ ïŒïœâïœïœ ïŒCoïŒtoæã®è¡äžçæ«éãïŒïœæã®è¡äžçæ«
éïŒ ãã®çµæã¯è¡šïŒã®ãšããã§ããã
â120ã®äžæž 液ãšæ¯èŒãããšãçŽæ¥çãªçŽ°èå·
害äœçšã§ããç现èã®éèœåœ¢æé»æ¢äœçšã¯ãã
ããŠåŒ±ãã (2) å ç«è³ŠæŽ»äœçš äžçŸ€ïŒå¹ã®ICRç³»ããŠã¹ãçšããå¶çæ§ç©è³ª
TFâ120ãççé£å¡©æ°Ž0.2mlã«æº¶è§£ããïŒmgå
ã³20mgïŒKgãè ¹è å æäžãããæäž24æéåŸã«
Perikan Drawing Ink 17 BlackïŒã®ãŠã³ã¿
ãŒã»ã¯ã°ããŒç€Ÿè£œïŒïŒmlãšãŒã©ãã³ïŒïŒ å«æç
çé£å¡©æ°ŽïŒmlãæ··åããŠèª¿è£œããã«ãŒãã³æµ®é
液0.2mlãããŠã¹å°Ÿéèããæ³šå ¥ããæ³šå ¥åŸ
ïŒãïŒã10ããã³15ååŸã«çŒçª©ãããããªã³è¢«
èŠãããã¯ãªããæ¯çŽ°ç®¡ãçšããŠè¡æ¶²0.02mlã
æ¡åããçŽã¡ã«0.1ïŒ çé žãããªãŠã 氎溶液1.6
mlã«åžé溶è¡ããããããæ³¢é·675nïœã§æ¯è²
ã貧é£ä¿æ°ïŒphagocytotic indexïŒïŒïŒ«å€ã
Halpernãã®æ°åŒã«ããæ±ããã ãŸãå¯Ÿç §çŸ€ã«ã¯ççé£å¡©æ°Ž0.2mlãæäžã
ãã ïŒïœïœïœ ïœâïœïœïœ ïŒïœâïœïœ ïŒCoïŒtoæã®è¡äžçæ«éãïŒïœæã®è¡äžçæ«
éïŒ ãã®çµæã¯è¡šïŒã®ãšããã§ããã
ãè¡šã
ãã®å®éšããæãããªããšãã察ç
§çŸ€ã«æ¯èŒ
ããæ¬çºæã®TFâ120æäžçŸ€ã¯ç¶²å ç³»ãã¯ãã
ã¢ãŒãžã掻æ§åãããæ£åžžããŠã¹ã®çŽ°èæ§å ç«
ãå¢å€§ããã (3) å¶çäœçš ãšãŒã«ãªããè ¹æ°Žåè «çã«å¯Ÿããæè «çäœçšïŒ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«ãšãŒã«ãªãã
è ¹æ°Žåç现èãããŠã¹ïŒå¹åœãïŒÃ105åè ¹è
å æ¥çš®ãããã€ãã§TFâ120ãççé£å¡©æ°Žã«æº¶
解ãããç现èæ¥çš®åŸïŒæ¥ç®ãããïŒæ¥ïŒåïŒ
æ¥éåéãé£ç¶æäžããããŸãå¯Ÿç §çŸ€ã«ã¯çç
é£å¡©æ°Ž0.1mlïŒïŒåãåæ§ã«æäžããã ãã®çµæã¯è¡šïŒã®ãšããã§ããã ïŒïŒ£ïŒæäžçŸ€ã®çåæ¥æ°ïŒå¯Ÿç §çŸ€ã®çåæ¥æ°Ã10
0ïŒïŒ ïŒ
ããæ¬çºæã®TFâ120æäžçŸ€ã¯ç¶²å ç³»ãã¯ãã
ã¢ãŒãžã掻æ§åãããæ£åžžããŠã¹ã®çŽ°èæ§å ç«
ãå¢å€§ããã (3) å¶çäœçš ãšãŒã«ãªããè ¹æ°Žåè «çã«å¯Ÿããæè «çäœçšïŒ ICRç³»ããŠã¹ïŒéãïŒé±ä»€ïŒã«ãšãŒã«ãªãã
è ¹æ°Žåç现èãããŠã¹ïŒå¹åœãïŒÃ105åè ¹è
å æ¥çš®ãããã€ãã§TFâ120ãççé£å¡©æ°Žã«æº¶
解ãããç现èæ¥çš®åŸïŒæ¥ç®ãããïŒæ¥ïŒåïŒ
æ¥éåéãé£ç¶æäžããããŸãå¯Ÿç §çŸ€ã«ã¯çç
é£å¡©æ°Ž0.1mlïŒïŒåãåæ§ã«æäžããã ãã®çµæã¯è¡šïŒã®ãšããã§ããã ïŒïŒ£ïŒæäžçŸ€ã®çåæ¥æ°ïŒå¯Ÿç §çŸ€ã®çåæ¥æ°Ã10
0ïŒïŒ ïŒ
ãè¡šã
ãã®å®éšããæãããªåŠãã察ç
§çŸ€ã«æ¯èŒ
ããæ¬çºæã®TFâ120æäžçŸ€ã«ã¯å»¶åœå¹æãèª
ããããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã¯æ¬¡ã«ç€ºãããšã
極ããŠæ¯æ§ãå°ãªãã ããŠã¹ã«ãããæ¥æ§æ¯æ§ïŒLD50ïŒ éè ïŒ250mgïŒKg è ¹è ïŒ1000mgïŒKg 以äžã®è¬çå®éšã®çµæããæãããªããã«ãæ¬
çºæã®å¶çæ§ç©è³ªTFâ120ã¯å¶çå€ãšããŠæçšãª
ãã®ã§ãããåçš®ã®ççŸæ£ã«äœ¿çšããå¹æãæåŸ
ããããã®ã§ãããããšãããåºåçã«å¯ŸããŠè
ããå¹æãæåŸ ã§ããã æ¬çºæã®TFâ120ã¯åžžæ³ã«ããçµå£ã泚å°ãå
è¬çã®å€åœ¢ã«ããŠäœ¿çšããããšãã§ãããçµå£å€
ãšããŠã¯çš®ã ã®è³Šåœ¢å€ãå«ãã§ããããã«ãã»ã«
å€ãé å€ãæ£å€ãé¡ç²å€ãšããããšãã§ããããŸ
ãã泚å°å€ãšããŠã¯ç®äžãçèå ãéèå 泚å°å€
ã®ãããã§ããããæžæ¿æ¶²ã溶液ãããã¯äœ¿çšæ
溶解ãããç²æ«çã®å€åœ¢ãçšããããããŸã泚å°
å€ã«ã¯å±æ麻é å€ãå«ãã§ããŠãããã æ¬çºæã®TFâ120ã®æäžéã¯æ£è ã®çç¶ã«å¿ã
ãŠé©å®éžæãããããäžè¬ã«æ人ã«ãããŠ0.01ã
50mgïŒKgãïŒæ¥ïŒãæ°åã«åãæäžããã®ã奜ãŸ
ãããæäžæ¹æ³ãšããŠã¯çµå£åã¯ç®äžãçèå ã
éèå ãããã¯æ£éšãžã®æ³šå°ã«ãã€ãŠãªãããã®
ã奜ãŸããã 次ã«æ¬çºæã®å®æœäŸãæããŠèª¬æããã å®æœäŸ ïŒ (1) ïŒå®¹ã®ã¹ã¯ãªãŠãŒãã€ããä»å¹é€ç¶15æ¬
ã«ãããããïŒæ¬ã«ã€ãããªããã±ãŒã¹ã»ãã
ãã³34ïœããã¢ã€ãã³ã»ãããã³ïŒïœãããã
ã¢ãŒãŒã»ãããã³20ïœããã¬ã€ã³ã»ããŒãã»ã€
ã³ããŠãŒãžãšã³70ïœãã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯
ãïŒïœãé£å¡©15ïœãã°ã«ã³ãŒã¹12ïœãã©ã¯ããŒ
ã¹10ïœãâã·ã¹ãã³0.5ïœãäºç¡«é žãœãŒã0.2
ïœãããªã°ãªã³ã¬ãŒãã»ãããªãŠã 1.0ïœãå¯
倩1.4ïœãå ãPHïŒã«èª¿æŽããå¹å°ïŒãå ¥
ãã120âã§15åéå å§æ» èããã®ã¡ããã ã¡
ã«æ°Žå·å·åŽããäºãåçµæã®å¹å°ã§åå¹é€ããŠ
ãããããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TF身
031ïŒåŸ®å·¥ç åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·ïŒã®
åå¹é€æ¶²ãå¹é€ç¶ïŒæ¬ã«ã€ã100mlã®å²åã§æ»
èæ¡ä»¶äžã«æ¥çš®ãã37âã®ãµåµåšäžã§48æéé
眮å¹é€ãè¡ããå¹é€çµäºåŸãïŒâã§4000r.p.
mã20åéãã®å¹é€æ¶²ãé å¿åé¢ãèäœãé€å»
ããŠäžæž 液çŽ27ãåŸãã (2) (1)ã§åŸãäžæž 液ã«ïŒâã§æ¹æäžã«ãšã¿ããŒã«
40ãå ããç¡å®åœ¢ã®æ²æŸ±ç©ãå®å šã«æ²æŸ±ãã
ãŸã§äœæž©å®€ã§æŸçœ®ãããã€ãã§ïŒâã§ã6000r.
p.mã15åéé å¿åé¢ãæ²æŸ±ç©ãæ¡åãããšã¿
ããŒã«ã§æŽæµããæžå§ä¹Ÿç¥ããŠçŽ60ïœã®ç²ç²æ«
ãåŸãã (3) (2)ã§åŸãç²ç²æ«20ïœãæ°Ž120mlã«æº¶è§£ããã
ã®éçããæ°Žäžæº¶ç©ã7500r.p.mã10åéé å¿
åé¢ã§é€å»ããŠåŸãäžæž 液ãšãæ°Žäžæº¶ç©ãæ°Ž60
mlã§ïŒåæŽæµããæŽæµæ¶²ãšãåããæ°Žå¯æº¶éš
230mlããããŒãã¢ã€ããŒåéå€éã·ã¹ãã
ïŒäœ¿çšèçªå·HIâïŒïŒæåæ(æ ª)補ååïŒãçšã
ãŠéå€éããå 液ãåçµä¹Ÿç¥ããTFâ110ã®
æ·¡ç°ãçœç°è²ã®ç²æ«10ïœãåŸãã (4) (3)ã§åŸãããç²æ«10ïœãå°éã®æ°Žã«æº¶è§£ãã
PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã«ãŠå¹³è¡¡äžãã
ãžãšãã«ã¢ãããšãã«âã»ãã¢ããã¯ã¹ïŒ¡â50
ãå å¡«ããã«ã©ã ã«ãããéé液ãæéããã
ããã«åäžã®ãªã³é žç·©è¡æ¶²2.5ãééããåŸ
ãããéé液ãšå ã«æéããéé液ãåããã
ãããããŒãã¢ã€ããŒåéå€éã·ã¹ãã ïŒäœ¿
çšèçªå·HIâïŒïŒãçšããŠè±å¡©ããã€ãã§æž
å§äžã«æ¿çž®ããåŸãåçµä¹Ÿç¥ããŠçœç°è²ãæ·¡è€
è²ã®ç®çç©ã®ç»åç²æ«470mgãåŸãã 補å€äŸ ïŒ å®æœäŸïŒã§åŸãããç²æ«ïŒmgããã€ã¢ç¶ã«å å¡«
ãããããã¯ã䜿çšææ» èæ°Žåã¯ãªãã«ã€ã³0.5
ïŒ å«æ溶液çã§æº¶è§£ã泚å°æ¶²ãšããŠçšããã
ããæ¬çºæã®TFâ120æäžçŸ€ã«ã¯å»¶åœå¹æãèª
ããããã æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã¯æ¬¡ã«ç€ºãããšã
極ããŠæ¯æ§ãå°ãªãã ããŠã¹ã«ãããæ¥æ§æ¯æ§ïŒLD50ïŒ éè ïŒ250mgïŒKg è ¹è ïŒ1000mgïŒKg 以äžã®è¬çå®éšã®çµæããæãããªããã«ãæ¬
çºæã®å¶çæ§ç©è³ªTFâ120ã¯å¶çå€ãšããŠæçšãª
ãã®ã§ãããåçš®ã®ççŸæ£ã«äœ¿çšããå¹æãæåŸ
ããããã®ã§ãããããšãããåºåçã«å¯ŸããŠè
ããå¹æãæåŸ ã§ããã æ¬çºæã®TFâ120ã¯åžžæ³ã«ããçµå£ã泚å°ãå
è¬çã®å€åœ¢ã«ããŠäœ¿çšããããšãã§ãããçµå£å€
ãšããŠã¯çš®ã ã®è³Šåœ¢å€ãå«ãã§ããããã«ãã»ã«
å€ãé å€ãæ£å€ãé¡ç²å€ãšããããšãã§ããããŸ
ãã泚å°å€ãšããŠã¯ç®äžãçèå ãéèå 泚å°å€
ã®ãããã§ããããæžæ¿æ¶²ã溶液ãããã¯äœ¿çšæ
溶解ãããç²æ«çã®å€åœ¢ãçšããããããŸã泚å°
å€ã«ã¯å±æ麻é å€ãå«ãã§ããŠãããã æ¬çºæã®TFâ120ã®æäžéã¯æ£è ã®çç¶ã«å¿ã
ãŠé©å®éžæãããããäžè¬ã«æ人ã«ãããŠ0.01ã
50mgïŒKgãïŒæ¥ïŒãæ°åã«åãæäžããã®ã奜ãŸ
ãããæäžæ¹æ³ãšããŠã¯çµå£åã¯ç®äžãçèå ã
éèå ãããã¯æ£éšãžã®æ³šå°ã«ãã€ãŠãªãããã®
ã奜ãŸããã 次ã«æ¬çºæã®å®æœäŸãæããŠèª¬æããã å®æœäŸ ïŒ (1) ïŒå®¹ã®ã¹ã¯ãªãŠãŒãã€ããä»å¹é€ç¶15æ¬
ã«ãããããïŒæ¬ã«ã€ãããªããã±ãŒã¹ã»ãã
ãã³34ïœããã¢ã€ãã³ã»ãããã³ïŒïœãããã
ã¢ãŒãŒã»ãããã³20ïœããã¬ã€ã³ã»ããŒãã»ã€
ã³ããŠãŒãžãšã³70ïœãã€ãŒã¹ãã»ãšã¯ã¹ãã©ã¯
ãïŒïœãé£å¡©15ïœãã°ã«ã³ãŒã¹12ïœãã©ã¯ããŒ
ã¹10ïœãâã·ã¹ãã³0.5ïœãäºç¡«é žãœãŒã0.2
ïœãããªã°ãªã³ã¬ãŒãã»ãããªãŠã 1.0ïœãå¯
倩1.4ïœãå ãPHïŒã«èª¿æŽããå¹å°ïŒãå ¥
ãã120âã§15åéå å§æ» èããã®ã¡ããã ã¡
ã«æ°Žå·å·åŽããäºãåçµæã®å¹å°ã§åå¹é€ããŠ
ãããããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã TF身
031ïŒåŸ®å·¥ç åèšçªå·åŸ®å·¥ç èå¯ç¬¬5077å·ïŒã®
åå¹é€æ¶²ãå¹é€ç¶ïŒæ¬ã«ã€ã100mlã®å²åã§æ»
èæ¡ä»¶äžã«æ¥çš®ãã37âã®ãµåµåšäžã§48æéé
眮å¹é€ãè¡ããå¹é€çµäºåŸãïŒâã§4000r.p.
mã20åéãã®å¹é€æ¶²ãé å¿åé¢ãèäœãé€å»
ããŠäžæž 液çŽ27ãåŸãã (2) (1)ã§åŸãäžæž 液ã«ïŒâã§æ¹æäžã«ãšã¿ããŒã«
40ãå ããç¡å®åœ¢ã®æ²æŸ±ç©ãå®å šã«æ²æŸ±ãã
ãŸã§äœæž©å®€ã§æŸçœ®ãããã€ãã§ïŒâã§ã6000r.
p.mã15åéé å¿åé¢ãæ²æŸ±ç©ãæ¡åãããšã¿
ããŒã«ã§æŽæµããæžå§ä¹Ÿç¥ããŠçŽ60ïœã®ç²ç²æ«
ãåŸãã (3) (2)ã§åŸãç²ç²æ«20ïœãæ°Ž120mlã«æº¶è§£ããã
ã®éçããæ°Žäžæº¶ç©ã7500r.p.mã10åéé å¿
åé¢ã§é€å»ããŠåŸãäžæž 液ãšãæ°Žäžæº¶ç©ãæ°Ž60
mlã§ïŒåæŽæµããæŽæµæ¶²ãšãåããæ°Žå¯æº¶éš
230mlããããŒãã¢ã€ããŒåéå€éã·ã¹ãã
ïŒäœ¿çšèçªå·HIâïŒïŒæåæ(æ ª)補ååïŒãçšã
ãŠéå€éããå 液ãåçµä¹Ÿç¥ããTFâ110ã®
æ·¡ç°ãçœç°è²ã®ç²æ«10ïœãåŸãã (4) (3)ã§åŸãããç²æ«10ïœãå°éã®æ°Žã«æº¶è§£ãã
PHïŒã®0.025ã¢ã«ãªã³é žç·©è¡æ¶²ã«ãŠå¹³è¡¡äžãã
ãžãšãã«ã¢ãããšãã«âã»ãã¢ããã¯ã¹ïŒ¡â50
ãå å¡«ããã«ã©ã ã«ãããéé液ãæéããã
ããã«åäžã®ãªã³é žç·©è¡æ¶²2.5ãééããåŸ
ãããéé液ãšå ã«æéããéé液ãåããã
ãããããŒãã¢ã€ããŒåéå€éã·ã¹ãã ïŒäœ¿
çšèçªå·HIâïŒïŒãçšããŠè±å¡©ããã€ãã§æž
å§äžã«æ¿çž®ããåŸãåçµä¹Ÿç¥ããŠçœç°è²ãæ·¡è€
è²ã®ç®çç©ã®ç»åç²æ«470mgãåŸãã 補å€äŸ ïŒ å®æœäŸïŒã§åŸãããç²æ«ïŒmgããã€ã¢ç¶ã«å å¡«
ãããããã¯ã䜿çšææ» èæ°Žåã¯ãªãã«ã€ã³0.5
ïŒ å«æ溶液çã§æº¶è§£ã泚å°æ¶²ãšããŠçšããã
第ïŒå³ã¯æ¬çºæã§çšããããœãã¯ããªãŠã ã»ã
ã¯ã¬ã¢ã¿ã TFâ031ã®åœ¢æ ã瀺ãé¡åŸ®é¡åçã第
ïŒå³ã¯æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã®èµ€å€ç·åžå
ã¹ãã¯ãã«ã第ïŒå³ã¯åç©è³ªã®çŽ«å€ç·åžåã¹ãã¯
ãã«ã第ïŒå³ã¯åç©è³ªãã»ãã¢ããã¯ã¹ïŒ§â200
ãçšããŠã²ã«éãããšãã®æº¶åºãã¿ãŒã³ã第ïŒ
å³ã¯åç©è³ªã®é«é液äœã¯ãããã°ã©ã ã瀺ãã
ã¯ã¬ã¢ã¿ã TFâ031ã®åœ¢æ ã瀺ãé¡åŸ®é¡åçã第
ïŒå³ã¯æ¬çºæã®å¶çæ§ç©è³ªTFâ120ã®èµ€å€ç·åžå
ã¹ãã¯ãã«ã第ïŒå³ã¯åç©è³ªã®çŽ«å€ç·åžåã¹ãã¯
ãã«ã第ïŒå³ã¯åç©è³ªãã»ãã¢ããã¯ã¹ïŒ§â200
ãçšããŠã²ã«éãããšãã®æº¶åºãã¿ãŒã³ã第ïŒ
å³ã¯åç©è³ªã®é«é液äœã¯ãããã°ã©ã ã瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â120çå·®èãå¹é€ãããã®å¹é€æ¶²ããåŸããã
次ã®æ§ç¶ãæããå¶çæ§ç©è³ªTFâ120ã (ã€) çœç°è²ãæ·¡è€è² (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°Žåçã®å¢æ®ãé»æ¢
ããå ç«è³ŠæŽ»äœçšãããã (ã) æ°Žã«æº¶è§£ãããã®æ°Žæº¶æ¶²ã¯ã»ãŒäžæ§ã瀺ãã
ã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»ãã³ããã³ãŒ
ã³ãã¯ãããã«ã ãé ¢é žãšãã«ããžãšãã«ãšãŒ
ãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ã2960ã2930ã1670ã1640ã1550ã
1380ã1360ã1140ã1000åã³820cm-1ã®è¿åã«
åžå垯ãæããã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€éšåžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã268ã272nïœã®è¿å
ã«åžåããŒã¯ã瀺ãã0.02ïŒ æ°Žæº¶æ¶²ã§ã®O.D260
ã¯0.060ã0.070ã®åžåã瀺ãã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®
ç»é²åæšïŒçšããŠã²ã«éïŒã«ã©ã ïŒ44mmÏÃ
500mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒã§
åç»ãããšã260nïœã®çŽ«å€ç·åžå 床枬å®ã«ã
ããŠã¯ããã€ãããªãŠã ééä»è¿ãã325mlä»
è¿ã«ãããŠãããã³775ãã875mlä»è¿ã«ãããŠ
åžå垯ãæããããšããŒã«ç¡«é žæ³ã«ããã
490nïœã®åžå 床枬å®ã«ãããŠã¯ããã€ãããª
ãŠã ééä»è¿ãã360ã360ãã480ããã³510ã
ã760mlä»è¿ã«ãããŠåžå垯ãæããã¢ã³ã¹ã
ã³ç¡«é žæ³ã«ããã620nïœã®åžå 床枬å®ã«ãã
ãŠã¯ãã€ãããªãŠã ééä»è¿ãã380ã420ãã
520ããã³620ãã760mlä»è¿ã«ãããŠåžå垯ã
æããã (ã) TSKâGEL G300 SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿã®
åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃÃïŒïŒã«ã
ãé«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®
0.1ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒ
ã¯ã220nïœããã³260nïœã®çŽ«å€ç·åžå 床枬å®
ã«ãããŠã¯ããããã溶åªå 端éšåã38ã60å
ä»è¿ã«ãããŠããŒã¯ãæããã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«âç¡«é žåå¿ã
ã¢ã³ã¹ãã³âç¡«é žåå¿ãã€ã³ããŒã«âå¡©é žå
å¿ãããŠãªã€ãŒããªãªã³åå¿ã¯éœæ§ããã³ãã
ãªã³åå¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ35.1ïŒ ã40.2ïŒ ã ïŒ4.5ïŒ ã5.5ïŒ ãïŒ2.0ïŒ ã3.1ïŒ (ã«) ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯56.0
ïŒ ã73.0ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ããŠãª
ã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯9.0
ïŒ ã13.0ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§ããã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â120çç£èãå¹é€ããŠåŸãå¹é€æ¶²åã¯äžæž 液ã«
芪氎æ§ææ©æº¶åªãå ããŠçããæ²æŸ±ç©ãæ¡åãã
ããã«æ°Žãå ããŠæ°Žäžæº¶ç©ãé€å»ãã次ãã§ãã
ãéæåã¯éå€éããæŽã«ãããã€ãªã³äº€æäœ
ã§åŠçããŠåŸããããã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ120ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â120çç£èãããœãã¯ããªãŠã ã»ãã¯ã¬ã¢ã¿ã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé èšèŒã®å¶
çæ§ç©è³ªTFâ120ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â120çç£èãå¹é€ããŠåŸãå¹é€æ¶²åã¯äžæž 液ã«
芪氎æ§ææ©æº¶åªãå ããŠçããæ²æŸ±ç©ãæ¡åãã
ããã«æ°Žãå ããŠæ°Žäžæº¶ç©ãé€å»ãã次ãã§ãã
ãéæåã¯éå€éããæŽã«ãããã€ãªã³äº€æäœ
åŠçããããšãç¹åŸŽãšããå¶çæ§ç©è³ªTFâ120ã®
補é æ³ã ïŒ èŠªæ°Žæ§ææ©æº¶åªãã¢ã«ã³ãŒã«ã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®å¶çæ§ç©è³ªTFâ120ã®è£œé
æ³ã ïŒ èŠªæ°Žæ§ææ©æº¶åªããã®æ¿åºŠã30ã70ïŒ ã«ãªã
ããã«å¹é€æ¶²åã¯äžæž 液ã«å ããããšãç¹åŸŽãšã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé èšèŒã®å¶çæ§
ç©è³ªTFâ120ã®è£œé æ³ã ïŒ ã€ãªã³äº€æäœåŠçã«ãããŠããªã³é žç·©è¡æ¶²ã§
åŠçããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®å¶çæ§ç©è³ªTFâ120ã®è£œé æ³ã ïŒ ããœãã¯ããªãŠã å±ã«å±ããå¶çæ§ç©è³ªTF
â120çç£èãå¹é€ãããã®å¹é€æ¶²ããåŸããã
次ã®æ§ç¶ (ã€) çœç°è²ãæ·¡è€è² (ã) ããŠã¹ã®ãšãŒã«ãªããè ¹æ°Žåçã®å¢æ®ãé»æ¢
ããå ç«è³ŠæŽ»äœçšãæããã (ã) æ°Žã«æº¶è§£ãããã®æ°Žæº¶æ¶²ã¯ã»ãŒäžæ§ã瀺ãã
ã¡ã¿ããŒã«ããšã¿ããŒã«ãã¢ã»ãã³ããã³ãŒ
ã³ãã¯ãããã«ã ãé ¢é žãšãã«ããžãšãã«ãšãŒ
ãã«ã«äžæº¶ã (ã) æ確ãªèç¹ã瀺ãããçŽ110âããå解ãå§
ãã200â以äžã§èããå解ããã (ã) KBré å€æ³ã«ããèµ€å€ç·åžåã¹ãã¯ãã«ã¯
3600ã3200ã2960ã2930ã1670ã1640ã1550ã
1380ã1360ã1140ã1000åã³820cm-1ã®è¿åã«
åžå垯ãæããã (ã) ãã®æ°Žæº¶æ¶²ã®çŽ«å€éšåžåã¹ãã¯ãã«ã¯åžåæ«
端ã«åŒ·ãåžåãããããŸã268ã272nïœã®è¿å
ã«åžåããŒã¯ã瀺ãã0.02ïŒ æ°Žæº¶æ¶²ã§ã®O.D260
ã¯0.060ã0.070ã®åžåã瀺ãã (ã) ã»ãã¢ããã¯ã¹ïŒ§â200ïŒãã¢ã«ãã·ã¢ç€Ÿã®
ç»é²åæšïŒãçšããŠã²ã«éïŒã«ã©ã ïŒ44mmÏ
Ã500mmã溶åºæ¶²ïŒPHïŒã®0.1ã¢ã«çé žç·©è¡æ¶²ïŒ
ã§åç»ãããšã260nïœã®çŽ«å€ç·åžå 床枬å®ã«
ãããŠã¯ãã€ãããªãŠã ééä»è¿ãã325mlä»
è¿ã«ãããŠãããã³775ãã875mlä»è¿ã«ãããŠ
åžå垯ãæããããšããŒã«ç¡«é žæ³ã«ããã
490nïœã®åžå 床枬å®ã«ãããŠã¯ããã€ãããª
ãŠã ééä»è¿ãã360ã360ãã480ãããã³510
ãã760mlä»è¿ã«ãããŠåžå垯ãæããã¢ã³ã¹
ãã³ç¡«é žæ³ã«ããã620nïœã®åžå 床枬å®ã«ã
ããŠã¯ãã€ãããªãŠã ééä»è¿ãã380ã420ã
ã520ããã³620ãã760mlä»è¿ã«ãããŠåžå垯
ãæããã (ã) TSKâGEL G300 SWïŒæ±æŽæ¹éæ ªåŒäŒç€Ÿã®
åååãã«ã©ã ïŒ7.9mmÏÃ600mmÃïŒïŒã«ãã
é«é液äœã¯ãããã°ã©ã ïŒæº¶åºæ¶²ïŒPHïŒã®0.1
ã¢ã«çé žç·©è¡æ¶²ãæµé0.8mlïŒåã宀枩ïŒã¯ã
220nïœããã³260nïœã®çŽ«å€ç·åžå 床枬å®ã«ã
ããŠã¯ããããã溶åªå 端éšåã38ã60åä»è¿
ã«ãããŠããŒã¯ãæããã (ãª) ã¢ãŒãªãã·ãŠåå¿ãããšããŒã«âç¡«é žåå¿ã
ã¢ã³ã¹ãã³âç¡«é žåå¿ãã€ã³ããŒã«âå¡©é žå
å¿ãããŠãªã€ãŒããªãªã³åå¿ã¯éœæ§ããã³ãã
ãªã³åå¿ã¯é°æ§ã (ã) å çŽ åæå€ ïŒ£ïŒ35.1ïŒ ã40.2ïŒ ãïŒ4.5ïŒ ã5.5ïŒ ïŒ®ïŒ2.0ïŒ ã3.1ïŒ (ã«) ããšããŒã«ç¡«é žæ³ã«ããç³ã®å«æçã¯56.0
ïŒ ã73.0ïŒ ïŒã°ã«ã³ãŒã¹æç®ïŒãããã³ããŠãª
ã€ãŒã»ããªãªã³æ³ã«ããèçœè³ªã®å«æçã¯9.0
ïŒ ã13.0ïŒ ïŒçè¡æž ã¢ã«ããã³æç®ïŒã§ããã ãæããå¶çæ§ç©è³ªTFâ120ãå«æããããšãç¹
城ãšããå¶çå€ã
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10781879A JPS5630997A (en) | 1979-08-24 | 1979-08-24 | Carcinostatic substance tf-120, its preparation, and carcinostatic comprizing it |
DE19803031152 DE3031152A1 (de) | 1979-08-24 | 1980-08-18 | Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben |
GB8027026A GB2059969B (en) | 1979-08-24 | 1980-08-19 | Fusobacterium culture extracts |
CA000358667A CA1174618A (en) | 1979-08-24 | 1980-08-20 | Substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same |
US06/180,040 US4744985A (en) | 1979-08-24 | 1980-08-21 | Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same |
AU61646/80A AU529076B2 (en) | 1979-08-24 | 1980-08-21 | Carcinostatic agents |
FI802641A FI68080C (fi) | 1979-08-24 | 1980-08-21 | Foerfarande foer framstaellning av karcinostatiska och immunostimulerande substansen |
AT0426480A AT375674B (de) | 1979-08-24 | 1980-08-21 | Verfahren zur herstellung neuer carcinostatischer substanzen |
CH6297/80A CH648042A5 (de) | 1979-08-24 | 1980-08-21 | Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben. |
BE0/201815A BE884864A (fr) | 1979-08-24 | 1980-08-21 | Nouvelles substances produites par des bacteries du genre fusobacterium, leur procede de preparation et leur application en therapeutique |
FR8018396A FR2463619A1 (fr) | 1979-08-24 | 1980-08-22 | Nouvelles substances produites par des bacteries du genre fusobacterium, leur procede de preparation et leur application en therapeutique |
NO802499A NO155697C (no) | 1979-08-24 | 1980-08-22 | Fremgangsmaate for fremstilling av fysiologisk aktive forbindelser ved fermentering. |
DD22346380A DD153999A5 (de) | 1979-08-24 | 1980-08-22 | Verfahren zur herstellung von substanzen mit carcinostatischer und immunstimulierender wirkung |
SE8005921A SE446406B (sv) | 1979-08-24 | 1980-08-22 | Nya foreningar med karcinostatisk och immunostimulerande verkan framstellda genom odling av fusobacterium nucleatum tf-031(ferm 5077, atcc 31647), forfarande for framstellning av desamma och karcinostatiskt medel inneha |
PT71730A PT71730A (en) | 1979-08-24 | 1980-08-22 | Process for preparing novel substances having carcinostatic immunostimulating activity and a carcinostatic agent containing the same |
NZ194744A NZ194744A (en) | 1979-08-24 | 1980-08-22 | Preparation of carcinostatic and immunostimulating tf-substances from fusobacterium |
NL8004759A NL8004759A (nl) | 1979-08-24 | 1980-08-22 | Nieuwe stoffen met carcinostatische en immuno- stimulerende werking, werkwijze voor de bereiding daarvan en carcinostatische preparaten die deze stoffen bevatten. |
IT49541/80A IT1181595B (it) | 1979-08-24 | 1980-08-22 | Sostanze carcinostatiche ed immuno stimolanti procedimento per prepararle ed agente carcinostatico che le contiene |
DK361680A DK151639C (da) | 1979-08-24 | 1980-08-22 | Fremgangsmaade til fremstilling af tf-100 eller fraktioner heraf med carcinostatisk og immunostimulerende aktivitet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10781879A JPS5630997A (en) | 1979-08-24 | 1979-08-24 | Carcinostatic substance tf-120, its preparation, and carcinostatic comprizing it |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5630997A JPS5630997A (en) | 1981-03-28 |
JPS627918B2 true JPS627918B2 (ja) | 1987-02-19 |
Family
ID=14468806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10781879A Granted JPS5630997A (en) | 1979-08-24 | 1979-08-24 | Carcinostatic substance tf-120, its preparation, and carcinostatic comprizing it |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5630997A (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA022546B1 (ru) * | 2011-09-28 | 2016-01-29 | ЀеЎеÑалÑМПе ÐПÑÑЎаÑÑÑвеММПе ÐÑЎжеÑМПе УÑÑежЎеМОе ÐаÑкО ÐÐœÑÑОÑÑÑ ÐОППÑгаМОÑеÑкПй ХОЌОО ÐÐŒ. ÐкаЎеЌОкПв Ð.Ð. КеЌÑкОМа РЮ.Ð. ÐвÑОММОкПва РПÑÑОйÑкПй ÐкаЎеЌОО ÐаÑк | СпПÑПб ÑПÑÐŒÐŸÐ¶ÐµÐœÐžÑ ÑПÑÑа каÑÑÐžÐœÐŸÐŒÑ ÑÑÐ»ÐžÑ Ð° Ñ Ð»Ð°Ð±ÐŸÑаÑПÑМПгП жОвПÑМПгП |
CN102696685B (zh) * | 2012-06-06 | 2013-08-14 | åå·åäžå€§åŠ | äžç§çšäºé²æ²»ççŽæ¡æºç¡ç ç泚干液å |
-
1979
- 1979-08-24 JP JP10781879A patent/JPS5630997A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5630997A (en) | 1981-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH021154B2 (ja) | ||
US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
US4209507A (en) | Novel anti-tumor substance and preparation thereof | |
JPS6320807B2 (ja) | ||
JPS627918B2 (ja) | ||
JPS627916B2 (ja) | ||
US4744985A (en) | Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same | |
JPS627917B2 (ja) | ||
FI79140B (fi) | Foerfarande foer framstaellning av ett tf-500-aemne med karsinostatisk och immunitet stimulerande aktivitet. | |
JPS6261036B2 (ja) | ||
KR890002256B1 (ko) | íì ë¬Œì§ tf-2 ì ì¡° ë°©ë² | |
FI69096C (fi) | Foerfarande foer framstaellning av en karcinostatisk och immunostimulerande tf-2-substans | |
JPS627919B2 (ja) | ||
FI68080C (fi) | Foerfarande foer framstaellning av karcinostatiska och immunostimulerande substansen | |
JPH0242478B2 (ja) | ||
JPS648637B2 (ja) | ||
JPH021156B2 (ja) | ||
JPH021153B2 (ja) | ||
JPH021151B2 (ja) | ||
JPH021152B2 (ja) | ||
JPS6353200B2 (ja) | ||
JPH03291232A (ja) | æè «çãå ç«è³ŠæŽ»å€ | |
JPS6353198B2 (ja) | ||
JPH039120B2 (ja) | ||
JPH021157B2 (ja) |